
Shire is to acquire rare diseases firm NPS Pharma to enhance its profile following the collapse of its deal with …
MHRA approves Romvimza for tenosynovial giant cell tumour
Panthera opens clinical trial site at Keele University
Santen joins inaugural Global Summit for Eye Health as partner

